Operating Income
ResMed Operating Income increased by 1.7% to $499.81M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.3%, from $426.27M to $499.81M. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 16.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Growth in operating income suggests that the core business is becoming more profitable and efficient.
Detailed definition
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
Peer comparison
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
operating_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $241.64M | $261.91M | $248.71M | $234.27M | $255.40M | $275.74M | $280.19M | $300.67M | $275.27M | $289.00M | $275.09M | $374.58M | $381.22M | $387.31M | $417.24M | $426.27M | $454.54M | $446.54M | $491.66M | $499.81M |
| QoQ Change | — | +8.4% | -5.0% | -5.8% | +9.0% | +8.0% | +1.6% | +7.3% | -8.4% | +5.0% | -4.8% | +36.2% | +1.8% | +1.6% | +7.7% | +2.2% | +6.6% | -1.8% | +10.1% | +1.7% |
| YoY Change | — | — | — | — | +5.7% | +5.3% | +12.7% | +28.3% | +7.8% | +4.8% | -1.8% | +24.6% | +38.5% | +34.0% | +51.7% | +13.8% | +19.2% | +15.3% | +17.8% | +17.3% |
Business Segments — Sleep and Respiratory Care
| Segment | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Respiratory Care | $352.56M | $373.37M | $390.70M | $330.50M | $390.42M | $426.39M | $456.18M | $408.36M |
| Total | $275.74M | $280.19M | $300.67M | $275.27M | $289.00M | $275.09M | $374.58M | $381.22M |
Software as a Service is derived from annual filings.
Sleep and Respiratory Care, Software as a Service, Software As Service, Total Sleep and Respiratory Care were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Sleep And Breathing Health
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Sleep And Breathing Health | $460.98M | $488.72M | $494.80M | $519.89M | $530.62M | $571.85M | $575.41M |
| Residential Care Software | $47.62M | $48.88M | $53.18M | $55.32M | $54.02M | $50.05M | $58.24M |
| Total | $387.31M | $417.24M | $426.27M | $454.54M | $446.54M | $491.66M | $499.81M |
Operating Income at Other Companies
Frequently Asked Questions
- What is ResMed's operating income?
- ResMed (RMD) reported operating income of $499.81M in Q1 2026.
- How has ResMed's operating income changed year-over-year?
- ResMed's operating income increased by 17.3% year-over-year, from $426.27M to $499.81M.
- What is the long-term trend for ResMed's operating income?
- Over 4 years (2021 to 2025), ResMed's operating income has grown at a 16.9% compound annual growth rate (CAGR), from $903.68M to $1.69B.
- What does operating income mean?
- The profit earned from core business activities, before accounting for interest and taxes.